A vaccine that protects against the omicron variant of COVID-19 could be made within 100 days, Pfizer and BioNTech announced Friday.
Pfizer said it is working to adapt the vaccine and monitoring for emerging strains of the virus, the most recent of which, B.1.1.529, known as “omicron,” was discovered by the World Health Organization in South Africa. BioNTech also said it is monitoring the highly transmissible “variant of concern.”
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.